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Introduction
Non-ischemic subclinical left-ventricular (LV) dysfunction may be a precursor to heart failure in patients with type 2 diabetes [1] . Early intervention to delay or reverse the progression of this diabetic cardiomyopathy may improve prognosis, though identifying appropriate therapy is difficult in the context of a poorly defined and multifactorial etiology.
An independent association with cardiac autonomic neuropathy points to distinct autonomic involvement [2] ; however, the undefined management of this complication limits its potential as a pathologic target [3] . Regression of autonomic dysfunction after exercise training has been reported in heart disease [4] [5] [6] [7] , but efficacy in type 2 diabetes remains equivocal [8] largely because of a reliance on uncontrolled cohort studies [9] . These studies have nonetheless shown promise in identifying favorable changes in heart-rate variability and other markers of cardiac autonomic function [9] . Indeed, autonomic adaptations may be independent of concurrent improvements in glycemic control and cardiovascular risk factors (by which exercise has a fundamental role in diabetes management) [10] [11] [12] .
Autonomic and LV functional responses to training may be directly related to improvements in exercise capacity [13, 14] . Clinically relevant increases in peak oxygen uptake (VO 2peak ; ~12%) are typical following exercise interventions in type 2 diabetes [15] , though secondary changes in LV function may not necessarily be observed [16] . However, prevailing data are largely from unselected type 2 diabetic cohorts and the relevance to patients with subclinical cardiomyopathy is unclear, particularly in view of exercise intolerance imposed by LV dysfunction [13] . Therefore, the primary aim of this controlled, proof-of-concept studyperformed in type 2 diabetic patients with non-ischemic subclinical LV dysfunction -was to evaluate the impact of a 6-month exercise intervention on cardiac autonomic function and VO 2peak . Heart-rate variability constituted the primary marker of autonomic function, though baroreflex sensitivity, conventional cardiac reflex tests and heart-rate profiles during exercise
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5 and recovery were also assessed. Echocardiography was performed to determine secondary changes in LV structure and function. We hypothesized that an improvement in VO 2peak
would mediate an increase in heart-rate variability, and that these collective benefits would promote LV structural and functional adaptations.
Methods
Patient selection. Asymptomatic patients with type 2 diabetes, aged ≥40 years, were screened for subclinical diastolic dysfunction by echocardiography (>1 standard deviation below the age-based normal septal early diastolic tissue velocity [Em] ) [17] between February 2009 and January 2011 (n=225). Exclusion criteria included known cardiovascular disease, psychiatric or other severe illness, symptomatic macro-or micro-vascular complications of diabetes, low ejection fraction (<50%), valvular disease, or ischemia (inducible wall motion abnormalities during exercise stress echocardiography).
Study design. This controlled trial (Australian New Zealand Clinical Trials Registry number
ACTRN12609000950268) was designed as a randomized study. However, recruitment difficulties secondary to restrictive inclusion criteria and substantive participant burden imposed by the intervention dictated observational patient enrolment as part of a nonrandomized, controlled design. Of those with non-ischemic subclinical diastolic dysfunction (n=81 after exclusion of two patients with occult coronary artery disease), 24 patients amenable to exercise participation were recruited into the 6-month intervention. A separate cohort of 25 patients who did not receive the exercise intervention underwent an identical 6-month follow-up assessment and served as controls [ Figure 1 ]. All patients continued to receive standard care from their treating physicians. Co-primary endpoints were VO 2peak and heart-rate variability (coefficient of variation of normal RR intervals [CVNN] ). Study Blood pressure (BP) was recorded in the supine position using an automatic brachial cuff.
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Carotid-femoral pulse wave velocity was recorded by applanation tonometry to determine aortic stiffness.
Exercise intervention. Individualized aerobic/resistance training programs were based on weekly exercise volumes recommended for type 2 diabetes (i.e. ≥150 minutes of moderate intensity or ≥90 minutes of vigorous intensity exercise) [10] . The intervention was administered by an accredited exercise physiologist via gym sessions (up to 75 minutes twice weekly, comprising 20-40 minutes of aerobic exercise and 6-12 resistance exercises) and home-based prescription. Target exercise intensity (moderate-vigorous) was primarily controlled using rating of perceived exertion, with intermittent verification by heart rate monitors. Subjects identifying facility access as a barrier to ongoing participation were offered substitute home-based exercise programs with telephone support and "refresher" gym sessions as an alternative to study withdrawal. A validated physical activity questionnaire determined adherence with the exercise prescription [16] .
Exercise testing. Patients performed maximal treadmill testing according to the Bruce protocol. Expired gas analysis for VO 2peak (applying 20-second interval data averaging) was measured using a standard commercial system (Vmax, SensorMedics, Yorba Linda, CA).
The chronotropic index was quantified by heart-rate reserve (peak -resting heart-rate) as a percentage of age-predicted heart-rate reserve (220 -age -resting heart-rate) [18] . Post-
exercise heart-rate recovery at 1-minute [18] and estimated maximum metabolic equivalents according to a standard formula for walking [19] were also recorded. Post-stress echocardiography was performed to exclude ischemia (i.e. inducible wall motion abnormalities).
Cardiac autonomic function testing. Patients were assessed in a quiet, temperate room following ≥15 minutes supine rest and instructed to relax, remain awake, and refrain from talking/moving. They were also asked to abstain from smoking and caffeine (12 hours), and alcohol, heavy exercise and antihypertensive medications (24 hours), as previously described [2, 18] . Heart-rate variability and baroreflex sensitivity were derived from 5-minute recordings of ECG (3-lead) and central (ascending aortic) BP. The latter was measured by continuous radial applanation tonometry (Colin CBM-7000; Colin Corp, Komaki-city, Japan), with generation of the central waveform using a validated transfer function [20] and commercial software (SphygomoCor; AtCor Medical, Sydney, Australia). ECG and central BP were digitized using a Powerlab 8SP data acquisition system (AD Instruments, Sydney, Australia) and stored for offline analysis using LabChart software (AD Instruments). RR intervals and beat-to-beat central systolic BPs were detected automatically and visually verified. Ectopic beats, in addition to intervals >20% different to their preceding interval, were interpolated [21] . Data were excluded when the interpolation rate exceeded 10%. Poor quality tonometry was responsible for missing baroreflex sensitivity data in 4 control-and 5 intervention-group patients, though heart-rate variability was still analysed in this cohort.
Heart-rate variability parameters were calculated as previously described [22] . These , and root-mean-square of differences in successive RR intervals) and frequency domain parameters (total power of heart-rate variability and its components within low-and high-frequency bands, normalized low-frequency power [i.e. low-frequency power
relative to the sum of low-and high-frequency power], and the ratio of low-/high-frequency power 
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Results
Clinical characteristics displayed in [ Table 1 ] and [Table 2 ] revealed that groups were similar at baseline except for the higher BP of patients allocated to exercise training. Follow-up data were analysed in all patients except for two in the intervention group (one withdrew for an unspecified reason and the other was excluded due to having undergone bariatric surgery).
Additional missing data for primary endpoints included heart-rate variability in one control and one intervention group patient (frequent ectopy dictated interpolation of >10% of RR intervals) and VO 2peak in a further three patients (two controls and one from the intervention group) due to technically inadequate expired gas measurements. Estimated metabolic equivalents for the latter patients were still analysed.
Of patients in the intervention group who completed the study (n=22), two had earlier withdrawn from exercise training altogether (citing loss of interest and lack of time) and five had ceased the gym-based component in favor of an exclusive home-based program.
Nonetheless, 95% of patients in the intervention reported exercise volumes that met or exceeded guidelines, which was significantly more than in the control group (64%; p=0.013).
Analyses of specific modes of physical activity revealed no difference between groups in time spent walking (p=0.87) or doing moderate intensity activities (p=0.81). However, the intervention group reported significantly more vigorous activity time than controls (p<0.001), which translated to greater total activity time (p=0.004). Table 2 ]. A reduction in waist circumference (but not body mass), and a borderline significant lowering of mean arterial pressure were observed in the intervention group. Within-group changes pointed to additional benefits for systolic BP and HDL cholesterol, but these were not significant relative to changes in the control group.
Changes in clinical characteristics [
BP reduction did not extend to changes in aortic stiffness. There was no relative improvement in diabetes control or other lipids. However, there was a tendency for a greater proportion of increase in the intervention group was borderline significant (p=0.073). Re-analysis following additional adjustment for mean arterial pressure (owing to the group difference in BP at baseline) did not affect these findings (data not shown). Table 3 ]. Of the wider battery of autonomic function tests, only the high-frequency power of heart-rate variability was significantly different between groups at baseline (lower in the intervention group; p=0.039).
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Secondary endpoints of cardiac autonomic function [
Markers of cardiac sympathovagal balance. Exercise training induced a significant decrease in resting heart-rate and a corresponding increase in its reciprocal (RR mean ). No changes in the low-/high-frequency ratio were observed.
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Heart-rate variability and baroreflex sensitivity. In contrast to CVNN, alternate markers of global heart-rate variability (SDNN and total spectral power) increased in the intervention group, with the change in total spectral power being significant relative to controls. Of specific heart-rate variability components, absolute (but not normalized) low-frequency power tended to improve in the intervention group (p=0.093), but neither the root-meansquare of differences in successive RR intervals, nor high-frequency power, benefited from the intervention. Baroreflex sensitivity remained unchanged in both groups.
Cardiac reflex tests. Deep breathing, Valsalva and orthostatic tests did not change in either group during the study.
Heart-rate profile during exercise and recovery. There was a trend toward improvement of the chronotropic index with exercise training (p=0.066), but no effects on heart-rate recovery were identified. Secondary endpoints of LV structure and function [ Table 4 ]. Echocardiography data were similar between groups at baseline except for higher E/A ratio in the intervention group (p=0.043). Ejection fraction and LV mass remained unchanged in both groups during the study. The sole parameter to improve with intervention was calibrated integrated backscatter.
Determinants of change in CVNN.
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Diastolic function. Em increased significantly and to a similar extent in both groups, resulting in no net benefit from the intervention. Of the more load-dependent parameters (adjusted for mean arterial pressure), there was a significant increase in the E/A ratio in controls. Notably, this was discordant with changes in LV filling pressure (E/e' ratio), which increased in the intervention group (albeit to a similar extent compared with controls).
Systolic function. The exercise intervention resulted in no favorable adaptations of systolic tissue velocity, strain, or strain rate, though the latter two variables increased in parallel in both groups during the study.
Discussion
In this controlled trial, a 6-month exercise intervention elicited a significant and clinically relevant improvement in exercise capacity (VO 2peak ) in type 2 diabetic patients with subclinical LV dysfunction. However, concomitant autonomic adaptations were absent on the basis of the primary measurement of heart-rate variability (CVNN) and reinforced by no changes in baroreflex sensitivity, heart-rate profiles during exercise and recovery, or cardiac reflex tests. The potential for a mechanism of benefit in relation to cardiac autonomic function should not altogether be excluded on the basis of a significant gain in total spectral power. The within-group change in CVNN after exercise training was also borderline significant. Together, these more positive findings from heart-rate variability may have been related to a favorable shift in cardiac sympathovagal balance (estimated by resting heart-rate), which was independently associated with ∆CVNN. Despite potential anti-fibrotic effects of exercise training (based on calibrated integrated backscatter), there were no secondary benefits for LV systolic or diastolic function.
Exercise capacity. Although improvements in exercise capacity of ~12% may be expected with exercise training in unselected patients with type 2 diabetes [15] , this is the first study to modification has recognized efficacy; however, the current 6-month exercise intervention failed to mediate regression of the primary endpoint of heart-rate variability (CVNN; a marker of parasympathetic function). Although CVNN indicated no effect, there was heterogeneity in responses of the wider battery of heart-rate variability indices (i.e. relative improvement in total spectral power, but not CVNN, SDNN, root-mean-square of differences in successive RR intervals, or low-or high-frequency power). CVNN was of most interest given superior sensitivity [36] and reproducibility [22] in diabetic patients and relative independence of resting heart-rate (by virtue of its definition as SDNN relative to RR mean ).
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The importance of this latter characteristic was highlighted by the present finding of RR mean lengthening (i.e. reduction of resting heart-rate) as an independent correlate of changes in CVNN and other heart-rate variability parameters (only data for CVNN is shown). This implicates the relative bradycardia induced by exercise training as responsible for significant within-and between-group changes in variables with a recognized relation to heart-rate (i.e.
15 SDNN and total spectral power) [37] . Findings based on these heart-rate variability markers are consistent with evidence in healthy individuals [38] and uncontrolled cohort studies of patients with type 2 diabetes [9] , which mostly support that the benefits of exercise training extend to an increase in heart-rate variability (i.e. beyond well-known improvements in cardiometabolic risk factors).
Regardless of whether an exercise-training-mediated relative bradycardia is responsible for concurrent changes in heart-rate variability, the clinical relevance of a reduction in the resting heart-rate must itself be recognised since higher resting heart-rate predicts adverse outcome
[39]. In the current study, the resting heart-rate was interpreted as an estimate of cardiac sympathovagal balance. This was because -aside from the intrinsic sinus depolarising rate, resting heart-rate is a product of the tonic sympathetic vs. parasympathetic input [40] [41].
Although inter-individual variation in the intrinsic rate introduces ambiguity to cardiac sympathovagal balance estimation from a single point estimate of resting heart-rate, changes over time may reflect alteration of this balance when stability of the intrinsic rate can be assumed. Of factors known to influence the intrinsic rate, the greatest threat to this assumption in the current study may have come from exercise training-mediated intrinsic electrophysiological adaptations [42] . However, since these are typically observed in highlytrained endurance athletes [42, 43], incidence in this relatively short-term intervention study is improbable. We therefore interpret the reduction of resting heart-rate to be of autonomic origin and to reflect a favorable shift in cardiac sympathovagal balance (i.e. an increase in parasympathetic tone, a reduction in sympathetic tone, or a combination of the two). It is acknowledged that this is discordant with the lack of a treatment effect on the low-/highfrequency ratio, which is purported have a similar physiological basis. This may be explained by our measurement of heart-rate variability solely from supine ECG recordings since patients with type 2 diabetes have previously shown training-induced improvements in the we support that conclusions about exercise training effects on cardiac sympathovagal balance in this study be interpreted as positive (i.e. based on resting heart-rate data).
Although we observed positive effects on some heart-rate variability and cardiac sympathovagal balance parameters, this did not extend to baroreflex sensitivity. This is in contrast to a trial in unselected type 2 diabetic patients, in which baroreflex sensitivity, but not heart-rate variability, was shown to improve following exercise training [8] . We also found heart-rate recovery to remain unchanged with exercise training, which was surprising given its strong association with exercise capacity [13] [14] , increases in tissue velocities in patients with worse function at baseline pointed to exercise being efficacious in patients with subclinical LV dysfunction [16] . In this context,
17 these negative findings were surprising. The study was not powered for LV functional endpoints, so the possibility of an inadequate sample size should be considered, particularly since the magnitude change in Em in the intervention group (1.1 cm/s) was clinically relevant and equivalent to that which may be expected with intensive pharmacologic therapy [49] . The basis of the significant increase in E/A ratio in controls is unclear since this marker is loaddependent and non-linear.
Study limitations.
Although clinical data indicated that groups were relatively similar at baseline and robust statistical strategies were employed to account for group differences, it is acknowledged that a randomised study is necessary to preclude unknown confounding imbalances and selection bias. The study also lacked blinding, although this is a common feature of exercise trials. Changes in medications may have confounded treatment effects on some of the study endpoints. In addition, although patients in the control group performed significantly less physical activity than those in the intervention, larger effect sizes may have been observed if comparisons had been made against completely sedentary controls.
The lack of significant improvement in HbA 1c represents an appealing culprit for some of the negative findings. However, this should not be interpreted as a failure to enhance the metabolic milieu because more patients in the intervention group reported reductions in hypoglycemic medication dose during the study. More sensitive markers of glycemic control and insulin sensitivity may have detected changes.
In view of the borderline significant within-group improvement of CVNN after exercise training, the prospect of inadequate statistical power for this co-primary endpoint must be considered. The present sample size was based on an expected improvement of 30% of the between-subject standard deviation [22] , which exceeded the observed change. The latter may constitute a clinically relevant effect that we were underpowered to detect. However, it is equally possible that our short-term reproducibility study [22] under-estimated 6-month 
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37 Highlights -A study of exercise for type 2 diabetes-related subclinical diastolic dysfunction.
-Exercise capacity improved by ~11% over 6 months vs. −1% in controls.
-Cardiac sympathovagal balance improved; other autonomic function data were mixed.
-The primary heart-rate variability endpoint did not significantly change.
-Possible anti-fibrotic effects did not extend to myocardial functional adaptations.
